Gene engineering bacterium for efficiently converting Echinocandin B and preparation method thereof

A technology of genetically engineered bacteria and echinocandin, which is applied in the field of genetically engineered bacteria that can efficiently transform echinocandin B and its preparation, can solve the problem of low efficiency of transforming echinocandin B and long growth cycle of actinomycetes. and other issues to achieve the effect of stable conversion efficiency

Inactive Publication Date: 2012-05-09
SHANGHAI INST OF PHARMA IND
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Therefore, the technical problem to be solved in the present invention is to provide a growth method aimed at the shortcomings of existing echinocandin B deacylase producing bacteria such as Actinomycetes mobilis with long growth cycle and low conversion efficiency of echinocandin B. Genetically engineered bacteria with shorter cycle and higher efficiency of transforming echinocandin B and preparation method thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene engineering bacterium for efficiently converting Echinocandin B and preparation method thereof
  • Gene engineering bacterium for efficiently converting Echinocandin B and preparation method thereof
  • Gene engineering bacterium for efficiently converting Echinocandin B and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1 Cloning of erythromycin resistance gene promoter and echinocandin B deacylase gene coding sequence

[0033] First, the total genome of the erythromycin-producing strain S.erythraea HL 3168E3 (ie S.erythraea ATCC11635) was used as a template to clone the erythromycin resistance gene promoter, the upstream primer: 5'-AAAAGATCTTCTAGAAGCCCGACCCGAGCA-3'; the downstream primer: 5' -AAAGAATTCTCCGGAGGTCGCACC-3', PCR was performed, and the resulting PCR product was purified and connected to plasmid pSP72 (purchased from Takara Company) to obtain plasmid pYG-LAJ-3, and sequenced, the sequence was compared with the online sequence (Gene ID: 4940594) Origin is 100%. The plasmid pYG-LAJ-3 was directly digested to obtain the erythromycin resistance gene promoter (EcoR I / Bgl II).

[0034] Primers were designed according to the echinocandin B deacylase gene and its sequence (Gene ID: 33036681) in GenBank, upstream: 5'-AAAAGATCTTCTAGAAGCCCGACCCGAGCA-3'; downstream: 5'-AAAGAAT...

Embodiment 2

[0036] Example 2 Construction of specific site integration plasmid, conjugative transfer

[0037] The erythromycin resistance gene promoter obtained in Example 1 and the fragment (XbaI / XbaI) of the echinocandin B deacylase gene coding sequence were connected into the plasmid pSET152 (XbaI / XbaI, dephosphorylated) purchased from Takara Company ) to obtain plasmid pYG-LAJ-6. This recombinant plasmid is an integrated plasmid containing the erythromycin resistance gene promoter and the echinocandin B deacylase gene coding sequence. This recombinant plasmid is used to transform Escherichia coli DH5α, and the transformants are picked and cultured in LB. The plasmid was digested and verified by PCR, and the site-specific integration plasmid pYG-LAJ-6 was finally constructed. The schematic diagram of the above plasmid construction process is shown in figure 1 .

[0038] Streptomyces lividans TK24 (CPCC 260835, derived from the Medicinal Microorganism Collection Center of China Commi...

Embodiment 3

[0039] Example 3 Screening of Specific Site Homologous Recombination Engineering Bacteria

[0040] The zygotes were picked and cultured in TSB containing abramycin (50 μg / ml), and then the bacterial solution was applied to a slant medium containing abramycin (50 μg / ml) (soluble starch 2.0%, NaCl 0.05%) , K 2 HPO 4 ·3H 2 O 0.05%, KNO 3 0.1%, MgSO 4 ·7H 2 O 0.05%, FeSO 4 ·7H 2 O 0.001%, purified agar powder 2.0%, pH 7.4), cultivated at 30°C. Because pSET152 contains phage The integration site (attP), which can be specifically homologously integrated with the attB site in the genome of Streptomyces lividans, integrates the abramycin resistance gene and erythromycin resistance gene carried by the plasmid pYG-LAJ-6 The promoter and echinocandin B deacylase gene were inserted into the attB site in the chromosome of Streptomyces lividans, and amplified synchronously with chromosome replication, and the zygote could stably express the abramycin resistance gene and Echinocan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a gene engineering bacterium for efficiently converting Echinocandin B and a preparation method thereof. The gene engineering bacterium is the engineering bacterium with an expression cassette of Echinocandin B acylase removal genes integrated in a genome of a wild strain of Streptomyces lividans. Through the conversion verification of the Echinocandin B, compared with that of the wild strain of Actinoplanes utahensis, the conversion speed of the gene engineering bacterium is improved by 1.5 times.

Description

technical field [0001] The invention belongs to the field of bioengineering, in particular to a genetic engineering bacterium for efficiently transforming echinocandin B and a preparation method thereof. Background technique [0002] In the past two decades, fungal infections that seriously endanger human life and health have been increasing in both frequency and type of infection, especially in immunosuppressed patients. In the nearly 30 years before the mid-1980s, amphotericin has been the main drug to control clinical fungal infections. Although its neurotoxicity is relatively high, there is no clinical choice. Until the successful development of imidazole and triazole antifungal drugs in the late 1980s and 1990s, fungal infections could be effectively and safely controlled clinically. However, with the use of these antifungal drugs, drug-resistant bacteria continue to emerge, so it is particularly important to find a new safe and effective antifungal drug. [0003] Ech...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/21C12N15/63C12N15/55C12P21/04C12R1/465
Inventor 李继安刘爱娟邵雷陈代杰周雨朦
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap